Mettler-Toledo International (NYSE:MTD) Upgraded by StockNews to "Buy"
StockNews upgraded shares of Mettler-Toledo International from a "hold" rating to a "buy" rating in a report on Sunday. Mettler-Toledo International (NYSE:MTD) has been upgraded by StockNews.com (StockNews) to a "buy" rating. The company was restated at a "sell" rating and set a $975.00 target price (down from $1,050.00). Citigroup also restated a sell rating and issued a buy rating on shares. The stock currently has a consensus rating of "Hold" and an average target price of $1.223.71. Despite disappointing Q4 results, analysts expect Mettler to post 39.9 earnings per share for the current year.
Published : 2 months ago by MarketBeat in Finance
Mettler-Toledo International (NYSE:MTD - Get Free Report) was upgraded by equities researchers at StockNews.com from a "hold" rating to a "buy" rating in a research report issued on Sunday.
Separately, Citigroup restated a "sell" rating and set a $975.00 target price (down previously from $1,050.00) on shares of Mettler-Toledo International in a report on Monday, December 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $1,223.71.
Check Out Our Latest Stock Analysis on Mettler-Toledo International
NYSE:MTD opened at $1,331.29 on Friday. The firm has a market capitalization of $28.48 billion, a PE ratio of 37.09, a price-to-earnings-growth ratio of 3.63 and a beta of 1.15. Mettler-Toledo International has a 12-month low of $928.49 and a 12-month high of $1,615.97. The firm has a 50-day moving average price of $1,250.06 and a 200 day moving average price of $1,154.62.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Friday, February 9th. The medical instruments supplier reported $9.40 earnings per share for the quarter, missing analysts' consensus estimates of $10.32 by ($0.92). Mettler-Toledo International had a net margin of 20.82% and a negative return on equity of 904.59%. The company had revenue of $934.90 million during the quarter, compared to the consensus estimate of $959.45 million. During the same quarter last year, the company earned $12.10 earnings per share. The business's revenue was down 11.6% on a year-over-year basis. On average, research analysts expect that Mettler-Toledo International will post 39.9 EPS for the current year.
In other Mettler-Toledo International news, Director Elisha W. Finney sold 251 shares of the company's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $1,177.35, for a total transaction of $295,514.85. Following the transaction, the director now directly owns 316 shares in the company, valued at approximately $372,042.60. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, insider Christian Magloth sold 400 shares of the company's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $1,278.73, for a total value of $511,492.00. Following the completion of the sale, the insider now owns 734 shares in the company, valued at $938,587.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Elisha W. Finney sold 251 shares of the firm's stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $1,177.35, for a total value of $295,514.85. Following the transaction, the director now owns 316 shares in the company, valued at approximately $372,042.60. The disclosure for this sale can be found here. Insiders sold a total of 951 shares of company stock worth $1,170,256 over the last three months. 1.94% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Norges Bank acquired a new stake in Mettler-Toledo International during the 4th quarter worth $428,679,000. PineStone Asset Management Inc. raised its position in shares of Mettler-Toledo International by 280.4% during the third quarter. PineStone Asset Management Inc. now owns 152,335 shares of the medical instruments supplier's stock worth $168,798,000 after purchasing an additional 112,291 shares during the period. Principal Financial Group Inc. lifted its holdings in shares of Mettler-Toledo International by 65.4% during the 4th quarter. Principal Financial Group Inc. now owns 241,219 shares of the medical instruments supplier's stock valued at $292,589,000 after purchasing an additional 95,421 shares in the last quarter. International Assets Investment Management LLC grew its position in shares of Mettler-Toledo International by 109,458.1% in the 4th quarter. International Assets Investment Management LLC now owns 67,926 shares of the medical instruments supplier's stock valued at $82,392,000 after purchasing an additional 67,864 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in Mettler-Toledo International by 26.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 326,105 shares of the medical instruments supplier's stock worth $471,369,000 after purchasing an additional 67,758 shares in the last quarter. 95.07% of the stock is owned by institutional investors.
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
• Five stocks we like better than Mettler-Toledo International
• Best ESG Stocks: 11 Best Stocks for ESG Investing
• 3 Value Stocks Too Small For Buffett’s Portfolio
• Foot Locker Builds Up Another Head of Steam; Gains Imminent
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Should you invest $1,000 in Mettler-Toledo International right now?
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Topics: Markets